- Home
- AZI vs MBRX Comparison
AZI vs MBRX Comparison
Compare AZI & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- MBRX
- Stock Information
- Founded
- AZI 2010
- MBRX 2015
- Country
- AZI China
- MBRX United States
- Employees
- AZI N/A
- MBRX N/A
- Industry
- AZI
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- MBRX Health Care
- Exchange
- AZI Nasdaq
- MBRX Nasdaq
- Market Cap
- AZI 25.2M
- MBRX 24.3M
- IPO Year
- AZI 2024
- MBRX 2016
- Fundamental
- Price
- AZI $0.21
- MBRX $0.49
- Analyst Decision
- AZI
- MBRX Strong Buy
- Analyst Count
- AZI 0
- MBRX 4
- Target Price
- AZI N/A
- MBRX $5.00
- AVG Volume (30 Days)
- AZI 3.5M
- MBRX 3.0M
- Earning Date
- AZI 01-01-0001
- MBRX 11-07-2025
- Dividend Yield
- AZI N/A
- MBRX N/A
- EPS Growth
- AZI N/A
- MBRX N/A
- EPS
- AZI N/A
- MBRX N/A
- Revenue
- AZI $156,466,000.00
- MBRX N/A
- Revenue This Year
- AZI N/A
- MBRX N/A
- Revenue Next Year
- AZI N/A
- MBRX N/A
- P/E Ratio
- AZI N/A
- MBRX N/A
- Revenue Growth
- AZI 32.90
- MBRX N/A
- 52 Week Low
- AZI $0.18
- MBRX $0.25
- 52 Week High
- AZI $3.20
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- AZI 45.82
- MBRX 56.47
- Support Level
- AZI $0.20
- MBRX $0.39
- Resistance Level
- AZI $0.21
- MBRX $0.51
- Average True Range (ATR)
- AZI 0.02
- MBRX 0.03
- MACD
- AZI 0.00
- MBRX 0.02
- Stochastic Oscillator
- AZI 38.40
- MBRX 87.04
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.